News & Events
Keep up to date with Isogenica’s latest news on collaborations, Press Releases, Events and VHH antibody resources.
Isogenica’s
Latest News

PEGS 2021: Isogenica presents latest VHH data
Isogenica is excited to announce its corporate sponsorship at PEGS November 2-4th 2021Isogenica is delighted to announce its attendance at PEGS Europe 2021 as Corporate Sponsors, were members of...
Esteemed Cancer Researchers Visit Isogenica
Isogenica welcomes MRC iCASE PhD Award successful applicant We were delighted to welcome Members of The Ernest and Helen Scott Haematological Research Institute at the University of...
Join Isogenica at ELRIG: Drug Discovery 2021
Isogenica is excited to announce its attendance at ELRIG: Drug Discovery October 19-20th 2021Isogenica's Research Scientist, David Knight, will be attending ELRIG: Drug Discovery 2021. David will...
Events
Isogenica are always looking to learn and connect at upcoming events and conferences.

Events
Resources
Due to their unique characteristics, VHH are promising candidates for a range of application areas including intracellular targeting and even across the Blood Brain Barrier (BBB). Discover all the benefits in using VHH in different applications.
Optimizing CAR-T and T-cell antibody engagers in haematological and solid tumours
A role for VHH single domain antibodies.
Isogenica’s PD-L1 VHH as Functional Antagonists
PD-1 is an immune checkpoint protein expressed on the surface of multiple types of immune cells, including antigen-stimulated T-cells and tumour specific T-cells1. Interaction between PD-1 and its...
Webinars
Webinars are a great source for the latest activities at Isogenica. Hear all about the newest applications of VHH.
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Isogenica’s
Newsletters
Catch up with Isogenica’s news and activies through the latest Newsletters.
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.